HFSA AHFTC Board Certification Review 2024

Overview

The HFSA AHFTC Board Certification Review 2024 is an on-demand educational product designed for healthcare providers seeking a comprehensive review of heart failure topics. This course supports clinicians preparing for the ABIM AHFTC certification examinations scheduled for November 2024 by delivering a detailed, high-quality overview aligned with the ABIM AHFTC blueprint.

On-demand cardiology education — accessible anytime, anywhere.

Format: Recorded presentations, slide decks, question bank, and attendee resources
Total size: Included downloadable content and full session recordings available

Agenda

This program provides a complete schedule of recorded sessions originally delivered in a multi-day live format. The agenda features extensive content covering heart failure pathophysiology, management, advanced therapies, and related subspecialty topics.

• Welcome and HFSA Introduction — Nancy Sweitzer, MD, PhD, FHFSA and Maria Rosa Costanzo, MD, FHFSA
• Live ABIM Style Question Session — Nancy Sweitzer, MD, PhD, FHFSA and Maria Rosa Costanzo, MD, FHFSA
• Hemodynamics in HF II — James C. Fang, MD, FHFSA
• Optimal Medical Therapy for HFrEF 1 — Mark Drazner, MD, MSc, FHFSA
• Optimal Medical Therapy for HFrEF 2 — Mark Drazner, MD, MSc, FHFSA
• Cardio Renal Failure Interactions in Heart Failure — Faculty
• Assessment of Functional Capacity Including Cardiopulmonary Exercise Testing — Gregory Lewis, MD
• Q&A – Faculty
• HFpEF: Epidemiology, Risk Factors, Diagnosis, Management (For the Boards) — Sanjiv Shah, MD
• Management of Comorbidities in Heart Failure: Iron Deficiency/Anemia — Gregory Lewis, MD
• Pulmonary Hypertension: Classification and Initial Evaluation — Jonathan Rich, MD, FHFSA
• Pulmonary Hypertension: Treatment — Jonathan Rich, MD, FHFSA
• Specific Etiologies of HF 1: HCM — Jane Wilcox, MD, MSc, FHFSA
• Specific Etiologies of HF 2: Other Inherited HF syndromes — Jane Wilcox, MD, MSc, FHFSA
• Specific Etiologies of HF 3: Infiltrative Disorders and Restrictive CMP — Sanjiv Shah, MD
• Q&A – Faculty
• Specific Etiologies of HF 4: Myocarditis and Inflammatory Cardiomyopathies — Maria Rosa Costanzo, MD, FHFSA
• Management of the Hospitalized HF Patient — Maria Rosa Costanzo, MD, FHFSA
• Advanced Heart Failure: Defining the Phenotype and Patient Selection for Advanced Therapies — Nancy Sweitzer, MD, PhD, FHFSA
• Immunology: The Basics, PRA, Sensitization, Crossmatch — Sean Pinney, MD, FHFSA
• Rejection: Cellular and Antibody Mediated — Sean Pinney, MD, FHFSA
• Heart Transplant, Clinical Outcomes and Complications — Michelle Kittleson, MD, PhD, FHFSA
• Managing Immunosuppression and Drugs — Michelle Kittleson, MD, PhD, FHFSA
• Pregnancy in HF — Kathryn Lindley, MD
• Cardiogenic Shock Management — Nancy Sweitzer, MD, PhD, FHFSA
• MCS 1: Durable MCS Devices and Outcomes — Joseph G. Rogers, MD
• MCS 2: Temporary Support Devices and ECMO for the Boards — Manreet Kanwar, MD
• MCS 3: Management of Complications of MCS — Manreet Kanwar, MD
• MCS 4: Interactive Shock and Device Management — Daniel Burkhoff, MD, PhD; Manreet Kanwar, MD; Joseph G. Rogers, MD; Nancy Sweitzer, MD, PhD, FHFSA
• Q&A – Faculty
• Adult Congenital Heart Disease for the HF Specialist — Eric V. Krieger, MD
• Management of Left Sided Valvular Heart Disease in Heart Failure — Jane Wilcox, MD, MSc, FHFSA
• Management of Common Arrhythmias 1: Atrial Fibrillation and Flutter — Roderick Tung, MD
• Management of Common Arrhythmias 2: Ventricular Arrhythmia — Roderick Tung, MD
• Device Therapy in Heart Failure I: Sudden Death Prevention — Christine Albert, MD, MPH
• Device Therapy in Heart Failure II: CRT — Christine Albert, MD, MPH
• Q&A – Faculty

Speakers

• Nancy Sweitzer, MD, PhD, FHFSA
• Maria Rosa Costanzo, MD, FHFSA
• James C. Fang, MD, FHFSA
• Mark Drazner, MD, MSc, FHFSA
• Gregory Lewis, MD
• Sanjiv Shah, MD
• Jonathan Rich, MD, FHFSA
• Jane Wilcox, MD, MSc, FHFSA
• Sean Pinney, MD, FHFSA
• Michelle Kittleson, MD, PhD, FHFSA
• Kathryn Lindley, MD
• Joseph G. Rogers, MD
• Manreet Kanwar, MD
• Daniel Burkhoff, MD, PhD
• Eric V. Krieger, MD
• Roderick Tung, MD
• Christine Albert, MD, MPH

This product is delivered by the Heart Failure Society of America (HFSA) and is available through the HFSA Learning Center as an on-demand resource.

Target Audience

This course is intended for cardiologists, heart failure specialists, advanced practice providers, and other healthcare professionals involved in the care of patients with heart failure who seek to review current standards and prepare for the ABIM AHFTC board certification examinations.

Why This Topic Matters

The HFSA AHFTC Board Certification Review 2024 addresses the critical need for up-to-date knowledge in heart failure management, including advanced diagnostics, medical therapies, and device-based interventions. It strengthens clinician expertise in a specialty that demands continual learning to manage complex patient populations effectively.

MedHub Central offers this authoritative cardiology education to support clinicians’ professional development and confidence in delivering evidence-based care. This review consolidates current heart failure concepts aligned with board certification requirements, benefiting cardiology practitioners aiming to maintain clinical proficiency.